載入...
Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
BACKGROUND: The perioperative use of antithrombotic therapy is associated with increased bleeding risk after cardiac implantable electronic device (CIED) implantation. Topical application of tranexamic acid (TXA) is effective in reducing bleeding complications after various surgical operations. Howe...
Na minha lista:
| 發表在: | BMC Cardiovasc Disord |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4841978/ https://ncbi.nlm.nih.gov/pubmed/27105588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-016-0251-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|